Trials / Unknown
UnknownNCT01514253
Reduced Infant Response to a Routine Care Procedure After Glucose 25% Analgesia in Comparison to Materna RTF Stage 1
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- The Baruch Padeh Medical Center, Poriya · Other Government
- Sex
- All
- Age
- 1 Day – 16 Days
- Healthy volunteers
- Accepted
Summary
Glucose has analgesic and calming effects in newborns. To date, it is not known whether the beneficial effects extend to care giving procedures that are performed after painful procedures. The investigators objective is to determine the effect of glucose 25% analgesia in comparison to Materna RTF Stage 1 for procedural pain on infant pain responses during a subsequent care giving procedure.
Detailed description
During hospitalization, a neonate undergoes a number of necessary procedures that may be either painful or cause discomfort to the baby. Pain experienced during the neonatal period is known to have long term effects on the baby. The red-reflex test is a routine examination performed on a neonate after birth and once again before discharge from the hospital. The examination causes discomfort to the infant Glucose has analgesic and calming effects in newborns. To date, it is not known whether the beneficial effects extend to care giving procedures that are performed after painful procedures. The investigators objective is to determine the effect of glucose 25% analgesia in comparison to Materna RTF Stage 1 for procedural pain on infant pain responses during a subsequent care giving procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glucose 25% | 1 ml glucose 25%, once |
| DIETARY_SUPPLEMENT | Materna RTF Stage 1 | 1ml Materna RTF Phase 1, 2-3 minutes prior red-reflex examination. |
| OTHER | Water for Injection | 1 ml Water for Injection (WFI), 2-3 minutes prior red-reflex examination |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2012-05-01
- Completion
- 2012-07-01
- First posted
- 2012-01-23
- Last updated
- 2012-01-23
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01514253. Inclusion in this directory is not an endorsement.